Citation Impact
Citing Papers
RNA Based Vaccines
2002 StandoutNobel
DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents
1999
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
1998 Standout
Vaccination for hepatitis C virus: closing in on an evasive target
2011
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application
2002
In vitro human Th-cell responses to a recombinant Hepatitis C Virus antigen: failure in IL-2 production despite proliferation
1999 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
The basis for HIV immunotherapeutic vaccines
2001
Development of albumin microspheres containing Sp H1-DNA complexes: A novel gene delivery system
2010
Approaches To New Vaccines
1998
Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization
1997
Exposing the immunology of naked DNA vaccines
1995
Expression and Immune Response to Hepatitis C Virus Core Dna-Based Vaccine Constructs
1996
Targeted antigen delivery to antigen–presenting cells including dendritic cells by engineered Fas-mediated apoptosis
2000
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Synthetic DNA vaccine strategies against persistent viral infections
2013
Gene vaccination: plasmid DNA is more than just a blueprint
1998
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
2004 StandoutNobel
Biomedical applications of biodegradable polymers
2011 Standout
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
PROSPECTS FOR A HEPATITIS C VIRUS VACCINE
1999 StandoutNobel
Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA
1999 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Controlled Delivery of Antigens and Adjuvants in Vaccine Development
1996
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Priming of Strong, Broad, and Long-Lived HIV Type 1 p55 gag -Specific CD8 + Cytotoxic T Cells after Administration of a Virus-Like Particle Vaccine in Rhesus Macaques
2000
The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine
1998
Transport of Nanoparticles Across the Rat Nasal Mucosa
2001
The Interaction of Immunodeficiency Viruses with Dendritic Cells
2003 StandoutNobel
Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines
2000
Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus
2000 StandoutNobel
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Nucleoside Modified mRNA Vaccines for Infectious Diseases
2016 StandoutNobel
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Protection against mycoplasma infection using expression-library immunization
1995 Nature
Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice
1997
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Molecular biology of flaviviruses
2003 StandoutNobel
Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA
1998 StandoutNobel
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity
2009
Plant cell cultures: Chemical factories of secondary metabolites
2002 Standout
DNA and RNA-based vaccines: principles, progress and prospects
1999
Immune responses to DNA vaccines
1999
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Genetic Immunization of Mice Against Listeria monocytogenes Using Plasmid DNA Encoding Listeriolysin O
1999
Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen
2003
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Augmentation and Suppression of Immune Responses to an HIV-1 DNA Vaccine by Plasmid Cytokine/Ig Administration
1998
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer
2000
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
1996
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope
1997 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Simian Immunodeficiency Virus (SIV)gagDNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection
2000
Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance
1999
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.
1995
DNA Vaccines: Progress and Challenges
2005
Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo
2000
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
DNA Vaccines: Immunology, Application, and Optimization
2000
Cytokines and costimulatory molecules as genetic adjuvants
1997
Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma
2003 StandoutNobel
Molecular Biology and Pathogenicity of Mycoplasmas
1998 Standout
In vivo protein expression from mRNA delivered into adult rat brain
2001 StandoutNobel
DNA vaccination: antigen presentation and the induction of immunity
2000
Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells.
2001
DNA Immunization with Japanese Encephalitis Virus Nonstructural Protein NS1 Elicits Protective Immunity in Mice
1998
Induction of Skin Fibrosis in Mice Expressing a Mutated Fibrillin-1 Gene
2000 StandoutNobel
Genetic immunization: a new era in vaccines and immune therapeutics
1997
Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
1997
Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d
2003
DNA VACCINES
1997
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
1997
Micellization of block copolymers
2003 Standout
Dengue and Dengue Hemorrhagic Fever
1998 Standout
A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo
1995
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
2019
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
2002
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Michael Merva being referenced
Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo
1994
DNA Inoculation Induces Neutralizing Immune Responses Against Human Immunodeficiency Virus Type 1 in Mice and Nonhuman Primates
1993
DNA Inoculation Induces Cross Clade Anti‐HIV‐1 Responses
1995
Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial
1997
Immunization by Direct DNA Inoculation Induces Rejection of Tumor Cell Challenge
1995
Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation
1995
Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site
1997
Genetic Infection Induces Protective In Vivo Immune Responses
1993
Induction of a TH1 type cellular immune response to the human immunodeficiency type 1 virus by in vivo DNA inoculation.
1998
DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells.
1994